Loratadine dysregulates cell cycle progression and enhances the effect of radiation in human tumor cell lines

Radiation Oncology

Volumn 5, Issue 1, 2010, Pages

  Soule, Benjamin P ^a   Simone, Nicole L ^a   DeGraff, William G ^a   Choudhuri, Rajani ^a   Cook, John A ^a   Mitchell, James B ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CHECKPOINT KINASE 1; CYCLIN B; LORATADINE; POLYDEOXYRIBONUCLEOTIDE SYNTHASE; CELL CYCLE PROTEIN; RADIOSENSITIZING AGENT;

ARTICLE; CELL CYCLE ARREST; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL CYCLE PHASE; CELL CYCLE PROGRESSION; CELL STRAIN HT29; CELL SURVIVAL; CLINICAL EVALUATION; CONTROLLED STUDY; CYTOTOXICITY; DNA DAMAGE; DNA FRAGMENTATION; DOWN REGULATION; DRUG MECHANISM; ENZYME ACTIVATION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; PROTEIN EXPRESSION; RADIATION DOSE; RADIATION EXPOSURE; RADIATION RESPONSE; RADIOSENSITIVITY; TUMOR CELL LINE; WESTERN BLOTTING; CELL CYCLE; DRUG EFFECT;

BLOTTING, WESTERN; CELL CYCLE; CELL CYCLE PROTEINS; DNA REPAIR ENZYMES; HT29 CELLS; HUMANS; LORATADINE; RADIATION TOLERANCE; RADIATION-SENSITIZING AGENTS;

EID: 77649087408     PISSN: None     EISSN: 1748717X     Source Type: Journal    
DOI: 10.1186/1748-717X-5-8     Document Type: Article

References (17)

1. Terasima T, Tolmach LJ. Changes in x-ray sensitivity of HeLa cells during the division cycle. Nature 1961, 190:1210-1211. 10.1038/1901210a0, 13775960.
2. Liebmann J, Cook JA, Fisher J, Teague D, Mitchell JB. In vitro studies of Taxol as a radiation sensitizer in human tumor cells. J Natl Cancer Inst 1994, 86:441-446. 10.1093/jnci/86.6.441, 7907149.
3. Chen JS, Lin SY, Tso WL, Yeh GC, Lee WS, Tseng H, Chen LC, Ho YS. Checkpoint kinase 1-mediated phosphorylation of Cdc25C and bad proteins are involved in antitumor effects of loratadine-induced G2/M phase cell-cycle arrest and apoptosis. Mol Carcinog 2006, 45:461-478. 10.1002/mc.20165, 16649252.
4. Huang TS, Shu CH, Chao Y, Chen SN, Chen LL. Activation of MAD 2 checkprotein and persistence of cyclin B1/CDC 2 activity associate with paclitaxel-induced apoptosis in human nasopharyngeal carcinoma cells. Apoptosis 2000, 5:235-241. 10.1023/A:1009652412399, 11225845.
5. Dunphy WG. The decision to enter mitosis. Trends Cell Biol 1994, 4:202-207. 10.1016/0962-8924(94)90142-2, 14731678.
6. Wilker EW, Grant RA, Artim SC, Yaffe MB. A structural basis for 14-3-3sigma functional specificity. J Biol Chem 2005, 280:18891-18898. 10.1074/jbc.M500982200, 15731107.
7. Parsels LA, Morgan MA, Tanska DM, Parsels JD, Palmer BD, Booth RJ, Denny WA, Canman CE, Kraker AJ, Lawrence TS, Maybaum J. Gemcitabine sensitization by checkpoint kinase 1 inhibition correlates with inhibition of a Rad51 DNA damage response in pancreatic cancer cells. Mol Cancer Ther 2009, 8:45-54. 10.1158/1535-7163.MCT-08-0662, 2730564, 19139112.
8. Ganzinelli M, Carrassa L, Crippa F, Tavecchio M, Broggini M, Damia G. Checkpoint kinase 1 down-regulation by an inducible small interfering RNA expression system sensitized in vivo tumors to treatment with 5-fluorouracil. Clin Cancer Res 2008, 14:5131-5141. 10.1158/1078-0432.CCR-08-0304, 18698031.
9. Shao RG, Cao CX, Pommier Y. Abrogation of Chk1-mediated S/G2 checkpoint by UCN-01 enhances ara-C-induced cytotoxicity in human colon cancer cells. Acta Pharmacol Sin 2004, 25:756-762.
10. Xiao Z, Xue J, Semizarov D, Sowin TJ, Rosenberg SH, Zhang H. Novel indication for cancer therapy: Chk1 inhibition sensitizes tumor cells to antimitotics. Int J Cancer 2005, 115:528-538. 10.1002/ijc.20770, 15688426.
11. Jin ZH, Kurosu T, Yamaguchi M, Arai A, Miura O. Hematopoietic cytokines enhance Chk1-dependent G2/M checkpoint activation by etoposide through the Akt/GSK3 pathway to inhibit apoptosis. Oncogene 2005, 24:1973-1981. 10.1038/sj.onc.1208408, 15674326.
12. Ren Q, Liu R, Dicker A, Wang Y. CHK1 affects cell sensitivity to microtubule-targeted drugs. J Cell Physiol 2005, 203:273-276. 10.1002/jcp.20222, 15389625.
13. Schwartz DC, Cantor CR. Separation of yeast chromosome-sized DNAs by pulsed field gradient gel electrophoresis. Cell 1984, 37:67-75. 10.1016/0092-8674(84)90301-5, 6373014.
14. Gardiner K, Laas W, Patterson D. Fractionation of large mammalian DNA restriction fragments using vertical pulsed-field gradient gel electrophoresis. Somat Cell Mol Genet 1986, 12:185-195. 10.1007/BF01560665, 3008351.
15. Ager DD, Dewey WC. Calibration of pulsed field gel electrophoresis for measurement of DNA double-strand breaks. Int J Radiat Biol 1990, 58:249-259. 10.1080/09553009014551601, 1974573.
16. Stamato TD, Denko N. Asymmetric field inversion gel electrophoresis: a new method for detecting DNA double-strand breaks in mammalian cells. Radiat Res 1990, 121:196-205. 10.2307/3577504, 2305038.
17. Sinclair WK. Cyclic x-ray responses in mammalian cells in vitro. Radiat Res 1968, 33:620-643. 10.2307/3572419, 4867897.